drugset / Trial / NCT00005826
Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of nitrocamptothecin in treating patients who have glioblastoma multiforme.
Timeline
- Start
- 2000-03
- Primary completion
- 2000-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rubitecan | Unknown | — | Oral |